Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AIkido Pharma Inc. stock logo
AIKI
AIkido Pharma
$5.27
+0.4%
$5.24
$3.31
$11.48
$28.91M0.9379,326 shs72,855 shs
Data Knights Acquisition Corp. stock logo
DKDCA
Data Knights Acquisition
$0.55
-12.5%
$0.42
$5.00
$13.51
$2.85M0.1839,705 shs200,027 shs
Luna Innovations Incorporated stock logo
LUNA
Luna Innovations
$0.95
+5.0%
$0.61
$0.22
$3.39
$32.09M1.96193,750 shs11,220 shs
Zymergen Inc. stock logo
ZY
Zymergen
$2.43
$2.52
$1.10
$12.42
$253.58M1.691.23 million shs85 shs
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AIkido Pharma Inc. stock logo
AIKI
AIkido Pharma
0.00%-5.05%+8.44%+45.18%+180.32%
Data Knights Acquisition Corp. stock logo
DKDCA
Data Knights Acquisition
0.00%+6.99%+53.06%+13.70%-37.95%
Luna Innovations Incorporated stock logo
LUNA
Luna Innovations
0.00%+5.00%+18.13%+162.50%-68.50%
Zymergen Inc. stock logo
ZY
Zymergen
0.00%0.00%0.00%0.00%0.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
AIkido Pharma Inc. stock logo
AIKI
AIkido Pharma
N/AN/AN/AN/AN/AN/AN/AN/A
Data Knights Acquisition Corp. stock logo
DKDCA
Data Knights Acquisition
N/AN/AN/AN/AN/AN/AN/AN/A
Luna Innovations Incorporated stock logo
LUNA
Luna Innovations
0.1824 of 5 stars
0.01.00.00.01.91.70.0
Zymergen Inc. stock logo
ZY
Zymergen
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AIkido Pharma Inc. stock logo
AIKI
AIkido Pharma
0.00
N/AN/AN/A
Data Knights Acquisition Corp. stock logo
DKDCA
Data Knights Acquisition
0.00
N/AN/AN/A
Luna Innovations Incorporated stock logo
LUNA
Luna Innovations
0.00
N/AN/AN/A
Zymergen Inc. stock logo
ZY
Zymergen
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AIkido Pharma Inc. stock logo
AIKI
AIkido Pharma
N/AN/AN/AN/A$19.27 per shareN/A
Data Knights Acquisition Corp. stock logo
DKDCA
Data Knights Acquisition
N/AN/A$0.00 per share111.42($1.82) per shareN/A
Luna Innovations Incorporated stock logo
LUNA
Luna Innovations
$116.61M0.28$0.31 per share3.03N/A
Zymergen Inc. stock logo
ZY
Zymergen
$16.74M15.15N/AN/A$3.99 per share0.61
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AIkido Pharma Inc. stock logo
AIKI
AIkido Pharma
-$7.17M-$3.88N/AN/AN/AN/A-18.21%-16.94%N/A
Data Knights Acquisition Corp. stock logo
DKDCA
Data Knights Acquisition
$340K-$0.19N/AN/AN/AN/A-5.55%N/A
Luna Innovations Incorporated stock logo
LUNA
Luna Innovations
$9.28MN/A0.00N/AN/AN/AN/AN/A
Zymergen Inc. stock logo
ZY
Zymergen
-$361.79M-$3.55N/AN/AN/A-2,508.94%-93.37%-61.14%N/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
AIkido Pharma Inc. stock logo
AIKI
AIkido Pharma
N/AN/AN/AN/AN/A
Data Knights Acquisition Corp. stock logo
DKDCA
Data Knights Acquisition
N/AN/AN/AN/AN/A
Luna Innovations Incorporated stock logo
LUNA
Luna Innovations
N/AN/AN/AN/AN/A
Zymergen Inc. stock logo
ZY
Zymergen
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
AIkido Pharma Inc. stock logo
AIKI
AIkido Pharma
N/A
29.54
29.54
Data Knights Acquisition Corp. stock logo
DKDCA
Data Knights Acquisition
N/AN/AN/A
Luna Innovations Incorporated stock logo
LUNA
Luna Innovations
N/AN/AN/A
Zymergen Inc. stock logo
ZY
Zymergen
N/A
4.59
4.47

Institutional Ownership

CompanyInstitutional Ownership
AIkido Pharma Inc. stock logo
AIKI
AIkido Pharma
10.88%
Data Knights Acquisition Corp. stock logo
DKDCA
Data Knights Acquisition
35.35%
Luna Innovations Incorporated stock logo
LUNA
Luna Innovations
87.46%
Zymergen Inc. stock logo
ZY
Zymergen
52.99%

Insider Ownership

CompanyInsider Ownership
AIkido Pharma Inc. stock logo
AIKI
AIkido Pharma
8.60%
Data Knights Acquisition Corp. stock logo
DKDCA
Data Knights Acquisition
45.72%
Luna Innovations Incorporated stock logo
LUNA
Luna Innovations
7.60%
Zymergen Inc. stock logo
ZY
Zymergen
11.70%
CompanyEmployeesShares OutstandingFree FloatOptionable
AIkido Pharma Inc. stock logo
AIKI
AIkido Pharma
45.49 million5.01 millionNot Optionable
Data Knights Acquisition Corp. stock logo
DKDCA
Data Knights Acquisition
25.17 million2.81 millionNot Optionable
Luna Innovations Incorporated stock logo
LUNA
Luna Innovations
39033.96 million31.38 millionOptionable
Zymergen Inc. stock logo
ZY
Zymergen
502104.36 million92.15 millionNot Optionable

Recent News About These Companies

SEC Penalizes Company for "Unsupported Hype"
Troubling Headlines for Emeryville Life Science Sector
Ohmium Announces Enakshi Singh as New Chief Financial Officer
Zymergen Investors Mostly Advance Claims Against Venture Funds
AI biotechs Exscientia and Recursion agree $688m merger
Ginkgo Bioworks: Broken Narrative

Media Sentiment Over Time

AIkido Pharma stock logo

AIkido Pharma NASDAQ:AIKI

$5.27 +0.02 (+0.38%)
As of 07/3/2025

AIkido Pharma Inc., a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia. The company is also developing an antiviral platform that inhibits replication of viruses, including influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2. It has license agreements with the University of Texas, University of Maryland Baltimore, Silo Pharma Inc., and Wake Forest University Health Sciences. The company was formerly known as Spherix Incorporated and changed its name to AIkido Pharma Inc. in March 2021. AIkido Pharma Inc. was founded in 1967 and is headquartered in New York, New York.

Data Knights Acquisition stock logo

Data Knights Acquisition NASDAQ:DKDCA

$0.55 -0.08 (-12.54%)
As of 07/3/2025

Data Knights Acquisition Corp. does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the data centers and internet technology sectors. Data Knights Acquisition Corp. was incorporated in 2021 and is based in Frome, the United Kingdom.

Luna Innovations stock logo

Luna Innovations NASDAQ:LUNA

$0.94 +0.05 (+5.00%)
As of 07/3/2025 10:44 AM Eastern

Luna Innovations Incorporated provides fiber optic test, measurement, and control products worldwide. The company offers test and measurement equipment for fiber optic components and sub-assemblies; polarization control products, including components, modules, and instruments to measure, manage, and control polarization and group delay in fiber optic networks; tunable lasers; and single frequency lasers. It also provides ODiSI sensing solution, which provides distributed strain and temperature measurements; distributed temperature sensing system; hyperion sensing products; Terahertz Sensing Systems that provide precise single and multi-layer thickness, density, basis weight, and caliper thickness measurements; and distributed acoustic sensing products. The company primarily markets its fiber optic test, measurement, and control products to telecommunications companies, defense agencies, government system integrators, researchers, original equipment manufacturers, distributors, testing labs, and strategic partners directly, as well as through manufacturer representative organizations, partner and distribution channels, technical sales engineers, value added resellers, and independent sales representatives. Luna Innovations Incorporated was incorporated in 1990 and is headquartered in Roanoke, Virginia.

Zymergen stock logo

Zymergen NASDAQ:ZY

Zymergen Inc. design, develop, and commercialize microbes, molecules, and materials. It offers an automation solution comprising reconfigurable automation carts, a modular hardware building blocks that allow for assembly of work cells customized for the particular needs of a lab; and automation control software, a cloud-based software used to control integrated automation systems. It serves electronics, packaging, healthcare, agriculture, and other industries. Zymergen Inc. was incorporated in 2013 and is based in Emeryville, California. As of October 19, 2022, Zymergen Inc. operates as a subsidiary of Ginkgo Bioworks Holdings, Inc.